{"pmid":32479748,"title":"Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.","text":["Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.","Braz J Infect Dis","Oliveira, Maria Helena Santos de","Wong, Johnny","Lippi, Giuseppe","Henry, Brandon Michael","32479748"],"journal":"Braz J Infect Dis","authors":["Oliveira, Maria Helena Santos de","Wong, Johnny","Lippi, Giuseppe","Henry, Brandon Michael"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479748","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.bjid.2020.05.002","locations":["Brazil","China","Italy"],"countries":["Italy","China","Brazil"],"countries_codes":["ITA|Italy","CHN|China","BRA|Brazil"],"topics":["Diagnosis"],"weight":1,"_version_":1668437835033608192,"score":9.490897,"similar":[{"pmid":32275075,"title":"Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.","text":["Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.","Coronavirus disease 2019 (COVID-19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),(1) has now progressed to global pandemic.(2) Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS-CoV-2 in humans to enable the development of appropriate interventions and therapies,(3,4) the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved.","J Med Virol","Lippi, Giuseppe","Mattiuzzi, Camilla","Sanchis-Gomar, Fabian","Henry, Brandon M","32275075"],"abstract":["Coronavirus disease 2019 (COVID-19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),(1) has now progressed to global pandemic.(2) Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS-CoV-2 in humans to enable the development of appropriate interventions and therapies,(3,4) the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lippi, Giuseppe","Mattiuzzi, Camilla","Sanchis-Gomar, Fabian","Henry, Brandon M"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275075","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25860","keywords":["covid-19","comorbidity","coronavirus","epidemics","mortality","outbreak"],"locations":["Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491649523712,"score":81.63851},{"pmid":32420921,"title":"Heterogeneity of COVID-19 outbreak in Italy.","text":["Heterogeneity of COVID-19 outbreak in Italy.","An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in December 2019 in China and was declared a pandemic on 11.03.2020 by WHO. Italy is one of the most afflicted Country by this epidemic with 136,110 confirmed cases and 16,654 deaths on 9.4.2020 (at the same date, the Ministry of Health was reporting 143,626 cases). During these few months the National Health Service have made a great effort to cope with the increasing request of intensive care beds and all the elective activities in hospital have been suspended. Data from the different Italian regions shows different patterns of positive and dead for this syndrome. Moreover, striking differences of the observed lethality of the infections among different areas were immediately evident from the epidemic reports. It will be of critical relevance to understand the expected evolution of the first lock-down phase, driving the exhaustion of the Covid-19 outbreak.(www.actabiomedica.it).","Acta Biomed","Rivieccio, Bruno Alessandro","Luconi, Ester","Boracchi, Patrizia","Pariani, Elena","Romano, Luisa","Salini, Silvia","Castaldi, Silvana","Biganzoli, Elia","Galli, Massimo","32420921"],"abstract":["An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in December 2019 in China and was declared a pandemic on 11.03.2020 by WHO. Italy is one of the most afflicted Country by this epidemic with 136,110 confirmed cases and 16,654 deaths on 9.4.2020 (at the same date, the Ministry of Health was reporting 143,626 cases). During these few months the National Health Service have made a great effort to cope with the increasing request of intensive care beds and all the elective activities in hospital have been suspended. Data from the different Italian regions shows different patterns of positive and dead for this syndrome. Moreover, striking differences of the observed lethality of the infections among different areas were immediately evident from the epidemic reports. It will be of critical relevance to understand the expected evolution of the first lock-down phase, driving the exhaustion of the Covid-19 outbreak.(www.actabiomedica.it)."],"journal":"Acta Biomed","authors":["Rivieccio, Bruno Alessandro","Luconi, Ester","Boracchi, Patrizia","Pariani, Elena","Romano, Luisa","Salini, Silvia","Castaldi, Silvana","Biganzoli, Elia","Galli, Massimo"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420921","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9579","locations":["China","Italy","Italian","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667254896708026369,"score":42.41986}]}